Current controversies in the USA regarding vaccine safety

Expert Review of Vaccines

Volumn 9, Issue 5, 2010, Pages 497-502

  Chatterjee, Archana ^a   Okeefe, Catherine ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CREIGHTON UNIVERSITY   (United States)

Author keywords

Controversies; Immunizations; Vaccine safety; Vaccines

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MERCURY; PERTUSSIS VACCINE; THIOMERSAL; VACCINE; WART VIRUS VACCINE;

ANTIBODY PRODUCTION; ANXIETY; AUTISM; B LYMPHOCYTE; BRAIN DISEASE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DRUG SAFETY; FEBRILE CONVULSION; FETUS CELL; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; HUMAN CELL CULTURE; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOMODULATION; INFANT; INTERPERSONAL COMMUNICATION; JUVENILE; LAW; MEASLES VIRUS; MEDICAL ETHICS; MORALITY; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PARENT; PARENTAL ATTITUDE; PRIORITY JOURNAL; RELIGION; REVIEW; SEXUAL BEHAVIOR; T LYMPHOCYTE; UNITED STATES; VACCINATION; VIRUS STRAIN;

HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; THERAPEUTIC MISCONCEPTION; UNITED STATES; VACCINATION; VACCINES;

EID: 77952202927     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.10.36     Document Type: Review

References (52)

1. Chen RT, Rastogi SC, Mullen JR et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12, 542-550 (1994).
2. Gust D, Weber D, Weintraub E, Kennedy A, Soud F, Burns A. Physicians who do and do not recommend children get all vaccinations. J. Health Commun. 13, 573-582 (2008).
3. Offit PA, Davis RL, Gust D. Vaccine safety. In: Vaccines (5th Edition). Plotkin SA, Orenstien WA, Offit PA (Eds). Saunders Elsevier, PA, USA, 1629-1650 (2008).
4. Allred NJ, Shaw KM, Santibanez TS, Rickert DL, Santoli JM. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002. Am. J. Prev. Med. 28(1), 221-224 (2005).
5. Gust DA, Strine TW, Maurice E. Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 114, E16-E22 (2004).
6. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N. Engl J. Med. 360 (19), 1981-1988 (2009).
7. Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and why. Pediatrics 122, 718-725 (2008).
8. Centers for Disease Control and Prevention. Multistate measles outbreak associated with an international youth sporting event - Pennsylvania, Michigan, and Texas, August-September 2007. MMWR Morb. Mortal. Wkly. Rep. 57(7), 169-173 (2008).
9. Centers for Disease Control and Prevention. Outbreak of measles - San Diego, California, January-February 2008. MMWR Morb. Mortal. Wkly. Rep. 57(7), 203-206 (2008).
10. Centers for Disease Control and Prevention. Invasive Haemophilus influenzae type b disease in five young children - Minnesota 2008. MMWR Morb. Mortal. Wkly. Rep. 58(3), 58-60 (2009).
11. Glanz JM, McClure DL, Magid DJ et al. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics 123, 1446-1451 (2009).
12. Wakefield AJ, Murch SH, Linnell J et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351, 637-641 (1998).
13. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hashika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig. Dis. Sci. 45, 723-729 (2000).
14. D'Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 118, 1664-1675 (2006).
15. DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin. Pharmacol. Ther. 82(6), 756-759 (2007).
16. Murch S. A statement by Dr Simon Murch. Allegations concerning our 1998 study. Lancet 363, 821-822 (2004).
17. The Editors of the Lancet. Retraction - ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375, 445 (2010).
18. Offit PA. Autism's False Prophets. Bad science, Risky Medicine, and the Search for a Cure. Columbia University Press, NY, USA (2008).
19. Institute of Medicine. Immunization Safety Review: Vaccines and Autism. National Academies Press, Washington DC, USA (2004).
20. Schechter R, Grether JK. Continuing increases in autism reported to California's developmental services system: mercury in retrograde. Arch. Gen. Psychiatry 65(1), 19-24 (2008).
21. Baker JP. Mercury, vaccines, and autism: one controversy, three histories. Am. J. Public Health 98, 244-253 (2008).
22. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics 104, 568-569 (1999).
23. Offit PA. Vaccines and autism revisited - the Hannah Poling case. N. Engl. J. Med. 358(20), 2089-2091 (2008).
24. Luño AR. Ethical reflections on vaccines using cells from aborted fetuses. Natl Cathol. Bioeth. Q. 6(3), 453-459 (2006).
25. Pruss AR. Complicity, fetal tissue, and vaccines. Natl Cathol. Bioeth. Q. 6(3), 461-470 (2006).
26. Fisher R, Darrow DH, Tranter M, Williams JV. Human papillomavirus vaccine: recommendations, issues and controversies. Curr. Opin. Pediatr. 20, 441-445 (2008).
27. Centers for Disease Control and Prevention (CDC). National, state and local area vaccination coverage - among adolescents, age 13 to 17 years, US - 2008. MMWR Morb. Mortal. Wkly. Rep. 58(36), 997-1001 (2009).
28. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 56(RR 2), 1-24 (2007).
29. Joura EA, Leodolter S, Hernandez-Avila M et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomized clinical trials. Lancet 369, 1693-1702 (2007).
30. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N. Engl. J. Med. 356, 1915-1927 (2007).
31. Slade BA, Leide L, Vellozzi C et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 302 (7), 750-757 (2009).
32. Haug C. The risks and benefits of HPV vaccination. JAMA 302, 795-796 (2009).
33. Charo RA. Politics, parents, and prophylaxis - mandating HPV vaccinations in the United States. N. Engl. J. Med. 336(19), 1905-1908 (2007).
34. Ohri LK. HPV vaccine: immersed in controversy. Ann. Pharmacother. 41, 1899-1902 (2007).
35. Eaton DK, Kann L, Kinchen S et al. Youth risk behavior surveillance - United States, 2005. Surveillance Summaries. MMWR Morb. Mortal. Wkly. Rep. 55, 1-108 (2006).
36. Greeberg DP, Wirsing von K?nig C-H, Heininger U. Health burden of pertussis in infants and children. Pediatr. Infect. Dis. J. 24(5), S39-S43 (2005).
37. Omer SB, Pan WKY, Halsey NA et al. Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA 296, 1757-1763 (2006).
38. Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch. Dis. Child. 49, 46-49 (1974).
39. Brown NJ, Berkovic SF, Scheffer IE. Vaccination, seizures and 'vaccine damage'. Curr. Opin. Neurol. 20, 181-187 (2007).
40. Romanus V, Jonsell R, Bergquist SO. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr. Infect. Dis. J. 6, 364-371 (1984).
41. Miller DL, Ross EM, Alderslade R et al. Pertussis immunization and serious acute neurological illness in children. Br. Med. J. 262, 1595-1599 (1981).
42. Robinson RJ. The whooping-cough immunization controversy. Arch. Dis. Child. 56, 577-580 (1981).
43. Baker JP. The Pertussis Vaccine Controversy in Great Britain, 1974-1986. Vaccine 21, 4003-4010 (2003).
44. Ray P, Hayward J, Michelson D. Encephalopathy after whole-cell pertussis or measles vaccination: Lack of evidence for a causal association in a retrospective case-control study. Pediatr. Infect. Dis. J. 25, 768-773 (2006).
45. Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine 25, 570-576 (2007).
46. Hilton S, Petticrew M, Hunt K. 'Combined vaccines are like a sudden onslaught to the body's immune system': parental concerns about vaccine 'overload' and 'immune vulnerability'. Vaccine 24, 4321-4327 (2006).
47. Centers for Disease Control and Prevention. Simultaneous administration of varicella vaccine and other recommended childhood vaccines - United States, 1995-1999. MMWR Morb. Mortal. Wkly. Rep. 50, 1058-1061 (2001).
48. Halsey N. Increased mortality after high-titer measles vaccines: too much of a good thing. Pediatr. Infect. Dis. J. 12, 462-465 (1993).
49. Gregson AL, Edelma R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol. Allergy Clin. N. Am. 23, 649-664 (2003).
50. Pickering LK, Orenstein WO. Active Immunization. In: Principles and Practice of Pediatric Infectious Diseases (3rd Edition). Long SS, Pickering LK, Prober CG (Eds). Elsevier Inc., PA, USA, 48-51 (2008).
51. Offit PA, Quarles J, Gerber MA et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics 109, 124-129 (2002).
52. Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 118, E1287-E1292 (2006).